ACADIA PHARMACEUTICALS INC
ACADUnited States
90 filed reports · 476 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
90 reports · Jun 2011 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 63 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 46 | 5,012 | Jun 2011 to Jun 2026 |
| Current · 8-KSEC EDGAR | 29 | 63 | Dec 2012 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 15 | 5,090 | Dec 2011 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 5, 2026 | 344 | Open |
| FY2026 Q2 | 8-K | Jun 30, 2026 | Aug 4, 2026 | 2 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 7, 2026 | 216 | Open |
| FY2026 Q1 | 8-K | Mar 31, 2026 | May 6, 2026 | 2 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 26, 2026 | 768 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Feb 25, 2026 | 2 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Jan 13, 2026 | 1 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 6, 2025 | 213 | Open |
| FY2025 Q3 | 8-K | Sep 30, 2025 | Nov 5, 2025 | 2 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 7, 2025 | 152 | Open |
| FY2025 Q2 | 8-K | Jun 30, 2025 | Aug 6, 2025 | 2 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 8, 2025 | 144 | Open |
Financial data
476 concepts · 10,165 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial462 concepts · 9,937 facts · Dec 2009 to Jul 2026
- Cash and cash equivalents at carrying value83 · Dec 2009 to Jun 2026
- Net income loss82 · Dec 2009 to Jun 2026
- Operating income loss82 · Dec 2009 to Jun 2026
- Research and development expense82 · Dec 2009 to Jun 2026
- Revenue82 · Dec 2009 to Jun 2026
- Depreciation81 · Dec 2009 to Jun 2026
- Increase decrease in accounts payable81 · Dec 2009 to Jun 2026
- Increase decrease in accrued liabilities81 · Dec 2009 to Jun 2026
- Proceeds from issuance of common stock81 · Dec 2009 to Jun 2026
- Stockholders equity (US GAAP)80 · Dec 2009 to Jun 2026
- Share based compensation79 · Dec 2009 to Jun 2026
- Accounts payable current78 · Dec 2010 to Jun 2026
- Accretion amortization of discounts and premiums investments78 · Dec 2010 to Jun 2026
- Accrued liabilities current78 · Dec 2010 to Jun 2026
- Assets78 · Dec 2010 to Jun 2026
- Assets current78 · Dec 2010 to Jun 2026
- Common stock par or stated value per share78 · Dec 2010 to Jun 2026
- Common stock shares authorized78 · Dec 2010 to Jun 2026
- Common stock shares issued78 · Dec 2010 to Jun 2026
- Common stock shares outstanding78 · Dec 2010 to Jun 2026
- Common stock value78 · Dec 2010 to Jun 2026
- Comprehensive income net of tax78 · Dec 2010 to Jun 2026
- Liabilities and stockholders equity78 · Dec 2010 to Jun 2026
- Liabilities current78 · Dec 2010 to Jun 2026
Segment10 concepts · 158 facts · Dec 2022 to Jun 2026
- Revenue42 · Dec 2022 to Jun 2026
- Cost of goods and services sold (US GAAP)14 · Dec 2022 to Jun 2026
- Income tax expense benefit14 · Dec 2022 to Jun 2026
- Interest income expense nonoperating net14 · Dec 2022 to Jun 2026
- Net income loss14 · Dec 2022 to Jun 2026
- Other nonoperating income expense14 · Dec 2022 to Jun 2026
- Research and development expense14 · Dec 2022 to Jun 2026
- Royalty expense14 · Dec 2022 to Jun 2026
- Selling general and administrative expense14 · Dec 2022 to Jun 2026
- Gain loss on sale of other assets4 · Dec 2022 to Dec 2025
Guidance2 concepts · 63 facts · Mar 2013 to Aug 2026
- Revenue Guidance59 · Aug 2017 to Aug 2026
- Free Cash Flow Guidance4 · Mar 2013 to May 2013
Product2 concepts · 7 facts · Dec 2016 to Dec 2018
- Revenue4 · Dec 2016 to Dec 2018
- Cost of goods and services sold (US GAAP)3 · Dec 2016 to Dec 2018
Segments
165 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments1 member · 158 facts
- Reportable Segment Aggregation Before Other Operating158 · Dec 2022 to Jun 2026
Product or service2 members · 7 facts
- Product6 · Dec 2016 to Dec 2018
- Product And Service Other1 · Dec 2016
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 4, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.